Greffex™ is a privately held, multi-national company, headquartered in Aurora, Colorado. Established in 1999, Greffex has developed a novel genetic platform for the development and production of vaccines. Our proprietary GREVAX™ Universal Platform delivers vaccines in a faster, more affordable and more efficient manner. Once a pathogen has been identified, Greffex’s team designs and produces a GREVAX™ vaccine in as little as 4 weeks. The state-of-the-art flexibility of the GREVAX™ Universal Platform makes it the ideal delivery vehicle for vaccines against a wide variety of infectious disease, including but not limited to Pandemic Influenza strains, Anthrax and Dengue Fever, as well as Malaria, Hepatitis C, Respiratory Syncytial Virus (RSV), Ebola, HPV, Plague, Tuberculosis and a host of other vaccine candidates.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 12635 E. Montview Blvd. Suite 280, Aurora,colorado 80045,united States
- Phone
- +1 866-723-4884
- jp****@****fex.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- greffex.com
- Keywords
- Fully Deleted Adenoviral Vectors, Vaccine Development, Packaging Plasmids, GREVAX Universal Platform, Gene Therapy.
- HQ
- Aurora, Colorado
Greffex, Inc. Questions
Greffex, Inc.'s helpline number is +1 866-723-4884
Greffex, Inc.'s website is greffex.com
Greffex, Inc.'s LinkedIn profile is https://www.linkedin.com/company/greffex-inc-
Greffex, Inc. has
15 employees.
View email and phone details for 15
employees at Greffex, Inc..
Greffex, Inc.'s industry is
Biotechnology Research
Greffex, Inc.'s top competitors are
Start3r,
Omix Technologies, Inc.,
Pathways Bioscience, Llc,
Avancebio,
Clinimmune Cell & Gene Therapy,
Western States Pathology Lab,
Goldenrod Therapeutics,
Edgewise Therapeutics,
Op-T Llc,
Bryan Laboratory, Inc.
Greffex, Inc.'s support email address is jprice@greffex.com
Greffex, Inc.'s categories are Biotechnology Research
Greffex, Inc.'s founding year is 1999
